|

Efimosfermin alfa Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 3: 2

Top Sponsors

  • GlaxoSmithKline3

Indications

  • Liver Disease3
  • Non Alcoholic Fatty Liver Disease3

Miami, Florida2 trials

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site

Phase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site

Phase 3

Other1 trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.